JLERI covers a wide range of topics in this area, including workplace ethics, regulatory compliance, ethical decision-making, ethics in business, legal ethics, and ethical issues in e-commerce. JLERI is associated with the publication of the Allied Business Academies and enjoys a 30% acceptance rate and promotes theoretical or empirical work in the fields of business law, ethics or governmental or regulatory issues. For more information about published manuscript types and accepted search categories, see the Journal Matrix section of this website. You can submit manuscripts online at: www.abacademies.org/submissions/journal-of-legal-ethical-and-regulatory-issues.html By email: [email protected] and/or [email protected] Journal of Legal, Ethical and Regulatory Issues (JLERI) is a bimonthly open access journal that hosts original research related to international trade laws and evolving legal rights. The ethical and legal issues surrounding the conduct of clinical research with human participants had been a concern for policymakers, lawyers, scientists and clinicians for many years. The Declaration of Helsinki established ethical principles for clinical research involving human participants. The goal of clinical research is to systematically collect and analyze data from which potentially generalizable conclusions can be drawn in order to improve clinical practice and benefit patients in the future. Therefore, it is important to be familiar with Good Clinical Practice (GCP), an international quality standard provided by the International Conference on Harmonization of Technical Requirements for Registration of Human Pharmaceuticals (ICH)[1] or the local version, Central Drugs Standard Control Organization (India`s equivalent of the U.S. Food and Drug Administration)[2] and local regulatory policy, Ensure that research is conducted in an ethical and legal manner.
In this article, we will briefly discuss the legal and ethical issues surrounding human recruitment, the basic principles of informed consent, and precautions to take when publishing data and clinical research. Some of the fundamental principles of PCM in research include defining the responsibilities of sponsors, researchers, monitoring and reviewing consent processes, and protecting individuals. [3] As a general rule, sponsors and authors are required to transfer certain publication rights to the journal by transfer of copyright or by a licensing agreement; After that, authors must obtain written permission from the journal/publisher if they wish to reuse material published elsewhere. [6] Authors and researchers have an ethical obligation to ensure the accuracy, publication and dissemination of research results[4] and to disclose relevant corrections, retractions and errata to publishers in order to protect the scientific integrity of published evidence. All research studies involving humans must be registered in a publicly accessible database (e.g. ANZCTR [Australia and New Zealand], ClinicalTrials.gov [US and non-US], CTRI [India]) and the results must be made public. [4] Clinical trial sponsors must grant all researchers and manuscript authors access to the full study dataset and have the right to use all study data for publication. [5] Source documents (with study data) and clinical study reports (study results and interpretation) are essential documentation that must be retained for a period required by applicable local legislation. [1] The ICMJE currently proposes a requirement for authors to share anonymized individual patient data underlying outcomes in articles in member journals. [18] Reasonable efforts should have been made to find legal authority to give consent. If there is not enough time, an “informed consent exception” may allow the subject to register with the prior consent of an ethics committee.
[7] Researchers should obtain the delayed informed consent of the investigator (if recapable) or his/her legally authorized representative for further participation as soon as possible. [4,7] The journal has also broadened its vision to invite interdisciplinary research and writing related to the future of the legal profession. Click here to view APA referencing procedures for online journal articles The Journal of Ethical and Legal Issues (JELI) publishes original, unpublished manuscripts on current ethical and legal issues. Topics such as plagiarism, academic integrity, corporate fraud, sexual harassment, white-collar crime, and criminal justice are appropriate topics in ethical and legal articles. This review is double-blind peer-reviewed with an acceptance rate of less than 40%. Co-editor: Dr. Steve Bain, professor and counseling center supervisor, Texas A&M University. Curriculum vitae. Contact: bain.editor@aabri.com. Co-editor: Dr.
James Larson, Professor and Chair, Department of Professional Studies, National University. Contact: larson.editor@aabri.com. Journal of Ethical and Legal Issues – Review Board ISSN Online: 2573-2404, Print: 2573-2390 See AABRI Journal Submission Procedures for instructions for authors. For more information on acceptance rates, archiving, review procedures, etc., see AABRI Publication Policies and Procedures. The journal is listed in Cabell`s directory of publishing opportunities. AABRI authors retain copyright in their manuscripts. For more information, see AABRI`s Copyright Policy. JELI is published by the Institute of Academic and Business Research. Please refer to www.aabri.com/procedures.html for AABRI journal submission procedures. Click on the manuscript name below to read articles from the Journal of Ethical and Legal Issues.
